Literature DB >> 21686901

An important clinical lesson from a patient infected with HIV with diabetic nephropathy and retinopathy.

Pasquale Martinelli1, Annalisa Agangi, Matilde Sansone, Raffaele Napolitano, Giuseppe Maria Maruotti.   

Abstract

In resource-rich settings, advances in antiretroviral therapy have reduced the morbidity and increased the life expectancy of patients infected with HIV and consequently increased the likelihood of observing other non-HIV-related diseases in this group of patients. We report a high-risk pregnancy in a 26-year-old woman infected with HIV with complicated insulin-dependent diabetes mellitus. Because of maternal concomitant disease and concerns regarding potential antiretroviral toxicity on maternal disease, an abbreviated regimen of zidovudine prophylaxis was offered to prevent neonatal infection. After the iatrogenic preterm delivery of a healthy and uninfected baby, the patient experienced vulvar oedema and she is now waiting for renal transplantation.In conclusion, our case is one of a range of possible scenarios that may develop in pregnant women who are infected with HIV, reflecting the highly active antiretroviral therapy (HAART)-associated improvements in survival and health.

Entities:  

Year:  2009        PMID: 21686901      PMCID: PMC3029002          DOI: 10.1136/bcr.06.2008.0200

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  10 in total

1.  Trends in diseases reported on U.S. death certificates that mentioned HIV infection, 1987-1999.

Authors:  Richard M Selik; Robert H Byers; Mark S Dworkin
Journal:  J Acquir Immune Defic Syndr       Date:  2002-04-01       Impact factor: 3.731

2.  Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States (revised November 3, 2000).

Authors: 
Journal:  HIV Clin Trials       Date:  2001 Jan-Feb

3.  Improved obstetric outcomes and few maternal toxicities are associated with antiretroviral therapy, including highly active antiretroviral therapy during pregnancy.

Authors:  Ruth E Tuomala; D Heather Watts; Daner Li; Mark Vajaranant; Jane Pitt; Hunter Hammill; Sheldon Landesman; Carmen Zorrilla; Bruce Thompson
Journal:  J Acquir Immune Defic Syndr       Date:  2005-04-01       Impact factor: 3.731

4.  Increasing likelihood of further live births in HIV-infected women in recent years.

Authors:  Annalisa Agangi; Claire Thorne; Marie-Louise Newell
Journal:  BJOG       Date:  2005-07       Impact factor: 6.531

Review 5.  Intensive care of patients with HIV infection.

Authors:  Laurence Huang; Andrew Quartin; Denis Jones; Diane V Havlir
Journal:  N Engl J Med       Date:  2006-07-13       Impact factor: 91.245

6.  ACOG technical bulletin. Diabetes and pregnancy. Number 200--December 1994 (replaces No. 92, May 1986). Committee on Technical Bulletins of the American College of Obstetricians and Gynecologists.

Authors: 
Journal:  Int J Gynaecol Obstet       Date:  1995-03       Impact factor: 3.561

7.  Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators.

Authors:  F J Palella; K M Delaney; A C Moorman; M O Loveless; J Fuhrer; G A Satten; D J Aschman; S D Holmberg
Journal:  N Engl J Med       Date:  1998-03-26       Impact factor: 91.245

8.  Antiretroviral therapies in pregnancy: maternal, fetal and neonatal effects. Swiss HIV Cohort Study, the Swiss Collaborative HIV and Pregnancy Study, and the Swiss Neonatal HIV Study.

Authors:  P Lorenzi; V M Spicher; B Laubereau; B Hirschel; C Kind; C Rudin; O Irion; L Kaiser
Journal:  AIDS       Date:  1998-12-24       Impact factor: 4.177

9.  Abbreviated regimens of zidovudine prophylaxis and perinatal transmission of the human immunodeficiency virus.

Authors:  N A Wade; G S Birkhead; B L Warren; T T Charbonneau; P T French; L Wang; J B Baum; J M Tesoriero; R Savicki
Journal:  N Engl J Med       Date:  1998-11-12       Impact factor: 91.245

Review 10.  Prevention of mother-to-child transmission of HIV infection.

Authors:  Claire Thorne; Marie-Louise Newell
Journal:  Curr Opin Infect Dis       Date:  2004-06       Impact factor: 4.915

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.